Findings from the SEIMC-GeSIDA Foundation (FSG) PASO-DOBLE study will include treatment efficacy, safety, and weight gain
The company is planning to expand its plant capacity in in Vapi
Dabur's consolidated revenue is expected to register mid to high single digit growth during Q1 FY25
Yann d’Hervé takes over responsibility for the Health Care business at Evonik, effective July 1
The initiative aimed to reach and support individuals suffering from epilepsy through early detection and effective disease management
Offering testing, treatment and support to help stop the spread of HIV and other infectious diseases
Approval based on FLAURA2 results which showed Tagrisso plus chemotherapy extended median progression-free survival by nearly 9 months vs. standard of care
The company has been entrusted with the responsibility of supplying a wide range of essential oncology drugs
Ascentage Pharma announces confidential submission of draft registration statement for proposed IPO
Transaction is non-dilutive, with 100% performance-based payment through a royalty model
Subscribe To Our Newsletter & Stay Updated
